06.03.2013 Views

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />

liq uids 17%<br />

gels/sols 17%<br />

med i cal dress ings 12%<br />

creams 9%<br />

SANDOZ<br />

Full Name: Sandoz S.A.S.<br />

Street Ad dress: 49, av e nue Geor ges Pompidou,<br />

92 593 Levallois Perret Cedex<br />

Tel: +33 1 49 64 48 00<br />

Fax: +33 1 49 64 48 48<br />

Home Page: www.sandoz.fr<br />

De scrip tion: De vel oper, for mu la tor, im porter,<br />

ex porter, pro moter, sales/detailer. De vel ops for<br />

other com pa nies. Prod uct ranges in clude: phar -<br />

ma ceu ti cal prod ucts (branded, unbranded, pre -<br />

scrip tion, non-pre scrip tion), hos pi tal<br />

pharmaceuticals, bio tech nol ogy prod ucts. Es tab -<br />

lished 2004. 223 phar ma ceu ti cal employees in<br />

2007.<br />

Con tacts (Pharm): Chair man: Ma rie-Josephe<br />

Baud<br />

Sub sid iary of: Novartis, Swit zer land (100%)<br />

Phar ma ceu ti cal Sales: US$ 440-450 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 25-30%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 50-55%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

90-95%<br />

Prin ci pal Prod ucts:<br />

OMEPRAZOLE SANDOZ (antiulcerant)<br />

VANCOMYCINE SANDOZ (an ti bac te rial other)<br />

SIMVASTATINE SANDO (cho les terol/triglyceride<br />

reg u lat ing prep a ra tion)<br />

AMOXI AC CLAV SAND (pen i cil lin broad spec trum)<br />

PRAVASTATINE SANDO (cho les terol/triglyceride<br />

reg u lat ing prep a ra tion)<br />

Ther a peu tic Range:<br />

antibacterials sys temic 18%<br />

lipid-reg u lat ing/antiatheroma prep a ra tions<br />

10%<br />

ant ac ids/antiflatulents/antiulcerants 9%<br />

psychoanaleptics 7%<br />

an al ge sics 7%<br />

Lead ing Dose Forms:<br />

coated tab lets 32%<br />

tab lets 26%<br />

cap sules 21%<br />

in fu sions 9%<br />

liq uids 4%<br />

GERMANY<br />

1A PHARMA<br />

Full Name: 1 A Pharma GmbH<br />

Street Ad dress: Keltenring 1 + 3, D-82041<br />

Oberhaching<br />

Tel: +49 6138825-0<br />

Fax: +49 6138825-25<br />

Email: info@1apharma.de<br />

Home Page: www.1apharma.de<br />

Sub sid iary of: Novartis, Swit zer land (100%)<br />

Phar ma ceu ti cal Sales: US$ 240-250 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 25-30%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 50-55%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

95-100%<br />

Prin ci pal Prod ucts:<br />

OMEPRAZOL-1A PHARM (antiulcerant)<br />

FENTANYL-1AP.BET.M (an al ge sic nar cotic)<br />

IBU 1A PHARMA (antirheumatic non-steroidal;<br />

an al ge sic non-nar cotic)<br />

SIMVASTATIN-1A PH. (cho les terol/triglyceride<br />

reg u lat ing prep a ra tion)<br />

METOPR.SUCCIN.1APH (beta-blocker agent<br />

plain)<br />

Ther a peu tic Range:<br />

an al ge sics 14%<br />

ant ac ids/antiflatulents/antiulcerants 13%<br />

antibacterials sys temic 9%<br />

beta-block ing agents 8%<br />

di uret ics 7%<br />

Lead ing Dose Forms:<br />

tab lets 42%<br />

coated tab lets 32%<br />

cap sules 17%<br />

med i cal dress ings 5%<br />

liq uids 4%<br />

CIBA VI SION<br />

Full Name: Ciba Vi sion Vertriebs GmbH<br />

Postal Ad dress: Postfach 10 02 24, D-63702<br />

Aschaffenburg<br />

Street Ad dress: Bauhofstrasse 16, D-63762<br />

Grossostheim<br />

Tel: +49 6026 941-0<br />

Fax: +49 6026 941-393<br />

Email: info@cibavision.de<br />

Home Page: www.cibavision.de<br />

De scrip tion: Pro moter, sales/detailer. Prod uct<br />

ranges in clude: oph thal mic prod ucts. 124 phar -<br />

ma ceu ti cal em ploy ees in 2005.<br />

© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 170

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!